Sorafenib Resistance Contributed by IL7 and MAL2 in Hepatocellular Carcinoma Can Be Overcome by Autophagy-Inducing Stapled Peptides.

To, Jeffrey C; Gao, Shan; Li, Xiao-Xiao; Zhao, Yanxiang; Keng, Vincent W

To, Jeffrey C; Gao, Shan; Li, Xiao-Xiao; Zhao, Yanxiang; Keng, Vincent W.

Afiliação

To JC; Shenzhen Research Institute, The Hong Kong Polytechnic University, Shenzhen 518057, China.
Gao S; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Li XX; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Zhao Y; Shenzhen Research Institute, The Hong Kong Polytechnic University, Shenzhen 518057, China.
Keng VW; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.

Cancers (Basel) ; 15(21)2023 Nov 03.

Article em En | MEDLINE | ID: mdl-37958451

Palavras-chave

IL7; MAL2; autophagy; hepatocellular carcinoma; sorafenib resistance; survival signaling pathways

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China